NL NLI HOLDINGS, INC.
Industrial Inorganic Chemicals · NYSE · SEC CIK 72162 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY4.3%
TTM net income YoY-150.9%
TTM EPS YoY-150.0%
Revenue 3-yr CAGR1.6%
Net income 3-yr CAGR—
Margins
Gross margin32.5%
Operating margin9.8%
Net margin-3.0%
FCF margin5.8%
EBITDA margin11.9%
Returns
ROE-1.3%
ROA-1.0%
ROIC (approx.)4.8%
Asset turnover0.34x
Leverage & solvency
Liabilities / assets19.8%
Debt / equity0.00x
Current ratio7.25x
Interest coverage369.50x
Cash quality & payout
Operating cash flow / net income-2.69x
Accruals ratio-3.7%
Payout ratio—
Capex / revenue2.2%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 |
|---|---|---|
| Income statement | ||
| Revenue | $158.28M | $145.94M |
| Cost of revenue | $110.11M | $104.58M |
| Gross profit | $48.18M | $41.36M |
| R&D expense | $0 | $0 |
| SG&A expense | $25.57M | $24.34M |
| Operating income | $10.68M | $37.88M |
| Interest expense | $767,000 | $530,000 |
| Pretax income | -$51.42M | $83.32M |
| Income tax | -$16.05M | $14.06M |
| Net income | -$37.83M | $67.23M |
| EBITDA | $14.33M | $41.57M |
| EPS (basic) | -0.77 | 1.38 |
| EPS (diluted) | -0.77 | 1.38 |
| Dividends declared per share | 0.57 | 0.75 |
| Weighted avg. shares (diluted) | 48.86M | 48.84M |
| Balance sheet | ||
| Cash & equivalents | $110.61M | $163.15M |
| Inventory | $30.41M | $28.37M |
| Current assets | $159.90M | $237.96M |
| PP&E, net | $23.71M | $24.03M |
| Goodwill | $27.16M | $27.16M |
| Total assets | $464.22M | $578.26M |
| Current liabilities | $20.58M | $91.06M |
| Total liabilities | $87.43M | $162.35M |
| Shareholders' equity | $358.77M | $396.90M |
| Shares outstanding | 48.86M | 48.85M |
| Cash flow statement | ||
| Operating cash flow | -$36.40M | $25.57M |
| Capital expenditure | $3.75M | $1.43M |
| Free cash flow | -$40.15M | $24.14M |
| Investing cash flow | -$2.44M | $58.87M |
| Financing cash flow | -$31.30M | -$41.63M |
| Depreciation & amortization | $3.65M | $3.69M |
| Dividends paid | $17.60M | $15.60M |
Free plan shows the latest 2 periods; Pro shows all 17 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.